Abnormal Cdk5 activity is implicated in several neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease and Huntington’s disease [2,3]. This evidence concerns the gene CDK5 and early-onset autosomal dominant Alzheimer disease.